Search - tctmd.com

Displaying 481 - 500 of 701

Sort: Relevancy | Date

News Daily News

ROADSTER IDE: Novel Transcarotid Stenting Technique Boosts Outcomes in High-Risk Patients

Yael L. Maxwell

February 04, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

January 28, 2015

News Daily News

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

Caitlin E. Cox

January 28, 2015

News Daily News

La Alta Mortalidad Post-Implantación de Stent Carotídeo en Pacientes de Medicare podría Comprometer los Beneficios del Tratamiento

January 28, 2015

News Industry News

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

December 14, 2014

News Daily News

German Registry Shows Trends in CAS Practice, Outcomes Over 15 Years

Yael L. Maxwell

December 04, 2014

News Daily News

Embolic Protection Stent Most Helpful in STEMI Patients With Large Thrombus

December 04, 2014

News Daily News

Un Registro Alemán revela Tendencias en la Práctica CAS y Resultados a los 15 Años

Yael L. Maxwell

December 04, 2014

News Daily News

El Stent de ‘Protección Embólica’ es Muy Útil en Pacientes STEMI con Trombos Grandes

December 04, 2014

News Daily News

Carotid Stenting, Endarterectomy Equally Effective at Preventing Severe Strokes in Symptomatic Patients

L.A. McKeown

October 24, 2014

News Daily News

La Implantación de Stents Carotídeos y la Endarterectomía son Igual de Efectivas en Pacientes Sintomáticos

L.A. McKeown

October 24, 2014

News Industry News

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

October 14, 2014

News Industry News

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

October 10, 2014

News Industry News

InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

September 18, 2014

Presentation TCT 2014

Outcomes with an Embolic Protection Stent in STEMI

Presenter: Francisco Fdez-Aviles, Abhiram Prasad, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Presenter: Marius Hornung

September 16, 2014

Presentation TCT 2014

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Presenter: Ferdinando Varbella

September 16, 2014

News Industry News

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

September 16, 2014

Presentation TCT 2014

The Emboline Aortic Embolic Protection Technology

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Scott Russell

September 15, 2014

Advertisement

ROADSTER IDE: Novel Transcarotid Stenting Technique Boosts Outcomes in High-Risk Patients

Registry Data Suggest Protection Up to 2 Years With LAA Closure

High Mortality After Carotid Stenting in Medicare Patients May Compromise the Treatment’s Benefits

Los Datos de Registro Sugieren Protección Hasta 2 Años con el Cierre del AAI

La Alta Mortalidad Post-Implantación de Stent Carotídeo en Pacientes de Medicare podría Comprometer los Beneficios del Tratamiento

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

German Registry Shows Trends in CAS Practice, Outcomes Over 15 Years

Embolic Protection Stent Most Helpful in STEMI Patients With Large Thrombus

Un Registro Alemán revela Tendencias en la Práctica CAS y Resultados a los 15 Años

El Stent de ‘Protección Embólica’ es Muy Útil en Pacientes STEMI con Trombos Grandes

Carotid Stenting, Endarterectomy Equally Effective at Preventing Severe Strokes in Symptomatic Patients

La Implantación de Stents Carotídeos y la Endarterectomía son Igual de Efectivas en Pacientes Sintomáticos

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease

InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

Outcomes with an Embolic Protection Stent in STEMI

Evaluation of flow reversal during carotid artery stenting as the first choice for embolic protection - no contraindications!

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

The Emboline Aortic Embolic Protection Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content